The ELEVATE trial (NCT05563220) is an ongoing part 1b/2 examine investigating elacestrant (Oserdu) mixed with numerous focused therapies for sufferers with endocrine rececptor-positive...
Weill Cornell Medication acquired a $1.5 million grant from the U.S. Division of Protection Prostate Most cancers Analysis Program to develop new approaches...
Please guarantee Javascript is enabled for functions ofweb site accessibilityRhode Island woman, 13, beats leukemia, celebrates at Hasbro Youngsters's HospitalWed, 03 Jul 2024...
